Ani Pharmaceuticals (ANIP) EPS (Diluted) Growth (1y) (2012 - 2026)
Ani Pharmaceuticals (ANIP) EPS (Diluted) Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 65.33% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 5.88% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -394.16% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -12.15% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 105.88% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 2,383.26% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -16.09% |
| 10 | Ani Pharmaceuticals | 1.64 Bn | 1.33 Bn | 143.88 Mn | 79.65% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 79.65% |
| Dec 31, 2025 | 334.19% |
| Sep 30, 2025 | 198.36% |
| Jun 30, 2025 | 387.54% |
| Mar 31, 2025 | -16.86% |
| Dec 31, 2024 | -1,443.19% |
| Sep 30, 2024 | -354.02% |
| Jun 30, 2024 | -142.64% |
| Mar 31, 2024 | 1,366.73% |
| Dec 31, 2023 | 114.40% |
| Sep 30, 2023 | 190.24% |
| Jun 30, 2023 | 134.71% |
| Mar 31, 2023 | 104.91% |
| Dec 31, 2022 | 85.19% |
| Sep 30, 2022 | -50.40% |
| Jun 30, 2022 | 19.29% |
| Mar 31, 2022 | -18,979.17% |
| Dec 31, 2021 | -535.64% |
| Sep 30, 2021 | -1,052.22% |
| Jun 30, 2021 | -12.65% |